Vanda Loses US Trade Secrets Battle Over Fanapt And Hetlioz Generics

 
• By Dean Rudge
  
trade secrets
The federal court said the dissolution specifications adopted by generics firms were not developed by Vanda. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Litigation

More from Legal & IP